PatternsRadar
Sign in

SUVENSuven Life Sciences Limited

NSE
269.40INR-7.50 (-2.71%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹7,612 CrMarket cap
—P/E (TTM)
48.1%Delivery

Filings & corporate actions

81 results filed
CSV
Next results · Q3 FY27
Expected 24 Jan 2027 – 3 Feb 2027
Estimate: filed 24–34 days after quarter end, last 5 times
Dividend
₹1.50 per share · last 14 Feb 2019
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone-4.1%NSE
  • 16 OctshareholdingShareholding · 30 Sept 2026+1.1%NSE
  • 6 AugresultsResults · Q1 FY27 · consolidated and standalone-2.7%NSE
  • 20 JulshareholdingShareholding · 8 Jul 2026+3.9%NSE
  • 16 JulshareholdingShareholding · 30 Jun 2026-4.2%NSE
  • 28 MayresultsResults · Q4 FY26 · standalone+4.6%NSE
  • 13 MayresultsResults · Q4 FY26 · consolidated and standalone-1.5%NSE
  • 16 AprshareholdingShareholding · 31 Mar 2026+2.1%NSE
  • 13 MarshareholdingShareholding · 6 Mar 2026+0.7%NSE
  • 29 JanresultsResults · Q3 FY26 · consolidated and standalone-0.6%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE

Reaction to results · all yearsrose on day 0 in 39 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026-4.1%+0.6%—0.5×
Q1 FY276 Aug 2026-2.7%0.0%+15.9%0.8×
Q4 FY2613 May 2026-1.5%+28.5%+27.9%0.8×
Q3 FY2629 Jan 2026-0.6%+29.0%+13.5%0.7×
Q2 FY2611 Nov 2025-2.6%-4.6%-10.2%1.0×
Q1 FY2613 Aug 2025+1.3%-0.6%-2.8%1.1×
Q4 FY2513 May 2025+7.5%+23.6%+44.2%6.6×
Q3 FY2524 Jan 2025-4.2%+7.3%-2.9%0.6×
Q2 FY2529 Oct 2024+5.3%+13.7%+10.1%1.5×
Q1 FY255 Aug 2024-4.7%-7.4%+8.4%0.6×
Q4 FY247 May 2024-5.0%-10.3%-21.9%0.9×
Q3 FY2430 Jan 2024-3.2%+5.0%-9.2%0.2×
Q2 FY244 Nov 2023+4.0%+10.5%+7.9%1.1×
Q1 FY248 Aug 2023+1.7%-0.5%-0.2%3.7×
Q4 FY2310 May 2023+0.4%-0.9%+1.6%0.5×
Q3 FY233 Feb 2023-1.7%-1.0%-6.3%1.2×
Q2 FY2311 Nov 2022+0.6%+1.5%+3.1%0.4×
Q1 FY2326 Jul 2022+1.2%+3.0%+1.4%0.9×
Q4 FY227 May 2022-3.0%+0.7%-6.8%0.5×
Q3 FY221 Feb 2022-0.4%-1.7%-12.0%0.3×
Q2 FY2226 Oct 2021+3.4%+5.7%-3.6%0.4×
Q1 FY2210 Aug 2021-6.6%-0.4%-0.4%1.4×
Q4 FY215 May 2021-3.1%-1.7%-4.8%0.8×
Q3 FY2128 Jan 2021-1.4%+14.8%+18.0%0.5×
Q2 FY2128 Oct 2020-2.4%-6.4%-4.6%0.5×
Q1 FY2112 Aug 2020-6.2%-1.7%-9.7%1.5×
Q4 FY206 Jun 2020-2.3%-9.6%+13.8%1.2×
Q3 FY2014 Feb 2020+5.0%+33.7%-16.0%2.7×
Q2 FY2014 Nov 2019-3.0%-2.6%-13.5%5.6×
Q1 FY2015 Aug 2019+0.8%+10.5%+22.5%0.7×
Q4 FY1925 May 2019+1.8%+1.6%+1.9%1.6×
Q3 FY191 Mar 2019+3.0%+6.2%+3.7%1.2×
Q2 FY1922 Nov 2018-1.5%-5.5%-11.8%0.5×
Q1 FY195 Sept 2018+4.3%+17.8%-6.2%0.7×
Q4 FY1826 May 2018+3.0%-3.2%+12.8%0.9×
Q3 FY1810 Feb 2018+2.4%-1.7%-9.3%0.4×
Q2 FY1822 Nov 2017+0.8%-1.4%-6.5%1.0×
Q1 FY181 Sept 2017+0.3%-3.1%+8.2%0.7×
Q4 FY1726 May 2017+6.2%+6.2%-2.0%1.9×
Q3 FY172 Feb 2017+1.0%+3.8%-3.0%0.8×
Q2 FY1728 Nov 2016-0.2%+2.7%-8.2%0.7×
Q1 FY1721 Sept 2016+0.4%+1.2%+5.5%0.5×
Q4 FY1630 May 2016-0.8%-2.2%-6.7%0.6×
Q3 FY1613 Feb 2016+0.5%-14.3%+16.9%3.8×
Q2 FY1610 Nov 2015+1.6%-1.6%-5.4%2.4×
Q1 FY1616 Aug 2015-3.2%-14.2%-10.2%1.6×
Q4 FY1528 May 2015+2.8%-8.2%-10.3%0.9×
Q3 FY1510 Feb 2015-3.1%+4.3%+4.8%1.2×
Q2 FY1522 Nov 2014-0.2%-0.4%+5.6%0.3×
Q1 FY1521 Aug 2014+1.6%+26.4%+55.1%1.3×
Q4 FY1427 May 2014+4.0%+9.7%+17.8%0.7×
Q3 FY145 Feb 2014-1.7%-6.8%-4.1%1.1×
Q2 FY1418 Nov 2013+8.5%+4.8%+6.9%2.9×
Q1 FY1419 Aug 2013+5.6%+9.7%+44.2%1.2×
Q4 FY1320 May 2013-2.6%-9.4%-11.8%0.5×
Q3 FY1312 Feb 2013+4.9%-2.2%-3.2%3.0×
Q2 FY1316 Nov 2012-6.2%-12.7%+8.9%0.7×
Q1 FY1314 Aug 2012+9.6%+29.1%+48.0%8.0×
Q4 FY127 May 2012-3.9%-9.0%-11.0%1.0×
Q3 FY1231 Jan 2012-0.6%+3.5%-7.3%2.2×
Q2 FY121 Nov 2011+0.3%-5.0%-12.6%5.4×
Q1 FY1218 Aug 2011+0.9%-2.6%-0.9%2.5×
Q4 FY1130 May 2011-0.9%+1.6%-8.9%0.7×
Q3 FY1131 Jan 2011-1.2%-6.0%-12.7%1.8×
Q2 FY1127 Oct 2010-1.0%-6.2%-10.9%1.4×
Q1 FY1127 Jul 2010-2.3%-3.1%-3.5%2.3×
Q4 FY1030 Apr 2010+5.0%-6.1%-15.2%1.5×
Q3 FY1027 Jan 2010-5.7%-3.5%-13.3%1.1×
Q2 FY1031 Oct 2009-4.5%-0.2%+3.4%0.8×
Q1 FY1028 Jul 2009-3.8%-5.6%+47.6%2.4×
Q4 FY0929 Apr 2009+0.7%+17.2%+73.1%0.4×
Q3 FY0919 Jan 2009+3.2%-0.7%-13.2%4.3×
Q2 FY0931 Oct 2008+20.0%+20.0%+12.3%4.6×
Q1 FY0925 Jul 2008+1.7%+9.3%-2.3%2.1×
Q4 FY0826 Apr 2008-4.4%-1.7%-2.9%0.6×
Q3 FY0828 Jan 2008-3.0%+4.7%-5.7%0.5×
Q2 FY0830 Oct 2007+4.0%-0.3%+6.0%3.0×
Q1 FY0810 Aug 2007+0.5%-4.4%-7.7%1.2×
Q4 FY0726 Apr 2007-0.1%-7.6%-14.3%2.6×
Average+0.3%+2.1%+2.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+30.4%
Profit YoY—
Interest cost YoY+13716.5%
Revenue QoQ-66.4%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue+4.0%-10.0%-13.9%+7.8%-13.6%—
Profit——————

Key data

Open277.25
Day range268.00 – 281.30
52-week range124.11 – 403.35
From 52w high-33.2%
RSI (14)44.3
ATR (14)13.70
Volume3.34L
Avg volume (20D)3.56L
Rel volume0.94×
Volatility (1Y)57.9%
Turnover₹9.1Cr
Traded value (NSE)₹9.1Cr
VWAP272.70
SMA 50 / 200297.02 / 257.69
Price band20%

Delivery percentage

Latest · 20 Nov 202648.1%
20-day avg40.8%
1-year avg42.9%
Percentile (own history)49th
Range7.4–100.0%
Sessions3,629

Over the last 20 sessions SUVEN settled 40.8% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 42.9%, so recent sessions are running 2.1 points lower than usual. The latest session ranks higher than 49% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders67.4K · +1.2% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy1,044 days ago
IndustryHealthcare Research Analytics & Technology

Performance returns

1D1W1M3M6M1Y
Price-2.71%-3.02%+0.45%-27.89%-0.04%+44.52%

Valuation

Market cap₹7,612 Cr
Market cap (NSE)₹7,612 Cr
Free-float cap₹2,629 Cr
P/E (TTM)—
P/E (NSE)—
EPS (TTM)-13.52
P/B16.8
Net margin (TTM)-4201.7%
Other income / PBT—
ROE-104.0%
Debt / equity0.00
Shares outstanding28.26Cr
Listed23 Oct 2003

Ownership

Promoter65.47%
Promoter Δ QoQ0.00 pp
Public34.53%
FII0.46%
DII2.17%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)2.81.53.61.2
YoY chg+74.5%+3.6%+91.0%+30.4%
Net profit (₹ Cr)(101.9)(45.6)(127.6)(106.9)
YoY chg————
Net margin-3628.8%-2999.5%-3578.7%-8922.3%
EPS-4.55-2.02-4.84-3.77

Shareholding over time

By quarter

30 Sept 2026 · promoter 65.47% · public 34.53%
30 Sept 2021: promoter 60.00%31 Dec 2021: promoter 60.00%28 Mar 2022: promoter 64.98%31 Mar 2022: promoter 64.98%30 Jun 2022: promoter 64.98%30 Sept 2022: promoter 64.98%16 Nov 2022: promoter 64.98%31 Dec 2022: promoter 69.57%31 Mar 2023: promoter 69.57%30 Jun 2023: promoter 69.57%30 Sept 2023: promoter 69.57%31 Dec 2023: promoter 69.57%31 Mar 2024: promoter 69.57%30 Jun 2024: promoter 70.27%30 Sept 2024: promoter 70.27%31 Dec 2024: promoter 70.27%31 Mar 2025: promoter 70.27%30 Jun 2025: promoter 70.27%16 Jul 2025: promoter 67.43%30 Sept 2025: promoter 67.36%31 Dec 2025: promoter 67.36%6 Mar 2026: promoter 70.15%31 Mar 2026: promoter 70.15%30 Jun 2026: promoter 70.08%8 Jul 2026: promoter 65.47%30 Sept 2026: promoter 65.47%
2021-092026-09
  • Promoter
  • Public and others
Promoter
65.47%
Public
34.53%
Promoter change
0.00 pp
Filed
16 Oct 2026
FII
0.46%
DII
2.17%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.08%

+0.07 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.45%

-0.03 pp QoQ

Retail ≤ ₹2L
17.70%

-0.01 pp QoQ

HNI > ₹2L
7.15%

+0.46 pp QoQ

NRI
1.46%

-0.01 pp QoQ

Bodies corporate
4.56%

+0.14 pp QoQ

Shareholders
67,431

+1.2% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED (In its Capacity as sole trustee of Jasti Family Trust)Promoter · Corporate64.93%
TEJAS TRIVEDIIndividual1.34%
KETAN C SHETHIndividual1.21%
SUDHARANI JASTIPromoter · Individual0.54%
VENKATESWARLU JASTIPromoter · Individual0.00%
KALYANI JASTIPromoter · Individual0.00%
SIRISHA JASTIPromoter · Individual0.00%
MADHAVI JASTIPromoter · Individual0.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 17 Sept 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2018-191₹1.50₹1.50
FY2017-181₹1.50₹1.50
FY2016-171₹1.00₹1.00
FY2015-162₹2.60₹2.60
FY2014-151₹2.50₹2.50
FY2013-141₹0.30₹0.30
FY2012-131₹0.30₹0.30
Ex-dateRecord dateDeclaredAdjusted
14 Feb 2019—₹1.50₹1.50
6 Feb 2018—₹1.50₹1.50
8 Feb 2017—₹1.00₹1.00
14 Mar 2016—₹2.00₹2.00
23 Jul 2015—₹0.60₹0.60
24 Jul 2014—₹2.50₹2.50
1 Aug 2013—₹0.30₹0.30
17 Sept 2012—₹0.30₹0.30

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
10.6 years ago
Disclosures on record
8
5 open-market of the newest 8
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
2 Sept 2020VENKATA RAMUDU JASTHIRelativeBuy15.0K₹7.4L49.3050.0K → 65.0K0.05%+0.01 pp7(2)told 1 Sept 2020
31 Aug 2020VENKATA RAMUDU JASTHIRelativeBuy10.0K₹5.4L53.8140.0K → 50.0K0.04%+0.01 pp7(2)told 29 Aug 2020
27 Aug 2020VENKATA RAMUDU JASTHIRelativeBuy20.0K₹10.5L52.7220.0K → 40.0K0.03%+0.01 pp7(2)told 27 Aug 2020
24 Aug 2020VENKATA RAMUDU JASTHIRelativeBuy20.0K₹10.0L50.01— → 20.0K0.02%7(2)told 24 Aug 2020
31 Mar 2016JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITEDPromoterBuy5.50L₹10.8Cr195.997.58Cr → 7.64Cr60.00%+0.43 pp7(2)told 30 Mar 2016

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 11 Jan 2024

CSV
12 of 18 deals
By year
DateDealClientQuantityPriceValue
11 Jan 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP14.29L121.82₹17.4Cr
11 Jan 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP14.29L121.70₹17.4Cr
13 Sept 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP15.35L78.20₹12.0Cr
13 Sept 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP15.35L78.12₹12.0Cr
23 Apr 2021Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.41L109.97₹7.0Cr
23 Apr 2021Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.41L109.64₹7.0Cr
17 Dec 2020Buy · bulkALPHA LEON ENTERPRISES LLP6.56L104.94₹6.9Cr
17 Dec 2020Sell · bulkALPHA LEON ENTERPRISES LLP6.27L105.08₹6.6Cr
18 Sept 2020Buy · bulkKATKAR SANJAY6.89L56.27₹3.9Cr
21 Apr 2020Sell · bulkALPHA LEON ENTERPRISES LLP7.62L32.17₹2.5Cr
21 Apr 2020Buy · bulkALPHA LEON ENTERPRISES LLP7.50L29.75₹2.2Cr
26 Mar 2020Buy · bulkALPHA LEON ENTERPRISES LLP7.44L24.86₹1.9Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • High-low range > 150% in 12 months · since 8 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 150% in 12 months.
  • High-low range > 200% in 1 year · since 1 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 200% in 1 year.
  • Zero EPS (4 quarters) · since 6 Dec 2024 — Zero EPS over the last four quarters.
  • Loss making · since 23 Jan 2024 — The company reported a loss.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25AQ4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations2.52.41.02.61.61.51.90.92.81.53.61.2
Other income6.14.34.04.01.61.20.63.82.86.87.56.7
Total income8.56.75.06.63.22.72.54.75.68.311.17.9
Total expenses50.334.233.156.342.446.654.082.0107.553.9138.7114.9
└ Finance costs0.00.00.00.00.00.00.00.00.00.20.50.5
└ Depreciation1.61.51.51.51.51.31.41.31.31.62.22.3
Profit before tax(41.8)(27.5)(28.0)(49.6)(39.1)(43.9)(51.5)(77.3)(101.9)(45.6)(127.6)(106.9)
Tax expense0.0(1.0)0.00.00.00.00.00.00.00.00.00.0
Net profit(41.8)(26.5)(28.0)(49.6)(39.1)(43.9)(51.5)(77.3)(101.9)(45.6)(127.6)(106.9)
EPS-1.92-1.22-1.29-2.27-1.79-2.02-2.36-3.48-4.55-2.02-4.84-3.77
Net margin-1704.13%-1112.72%-2787.25%-1929.49%-2429.75%-2995.56%-2759.78%-8410.56%-3628.79%-2999.51%-3578.73%-8922.25%
PBT margin-1704.13%-1154.75%-2787.25%-1929.49%-2429.75%-2995.56%-2759.78%-8410.56%-3628.79%-2999.51%-3578.73%-8922.25%
Tax rate————————————

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets388.9350.3284.9212.0135.2337.4624.2506.4
Current assets251.6216.0256.7186.675.5278.2546.7383.3
└ Cash & equivalents37.018.614.97.415.09.68.324.1
└ Other bank balances147.3105.4149.085.122.71.2329.2308.9
└ Current investments46.364.475.974.022.3246.70.013.7
└ Trade receivables0.81.01.31.51.31.11.51.5
└ Inventories0.00.70.70.70.20.20.10.1
Total equity375.3338.4270.0192.7110.0281.3591.4453.6
└ Attributable to owners375.3338.4270.0192.7110.0281.3591.4453.6
└ Non-controlling interest0.0——0.0—0.0——
└ Share capital21.821.821.821.821.822.726.428.3
Borrowings0.00.00.00.20.00.00.00.0
└ Current0.00.00.00.20.00.00.00.0
└ Non-current0.00.00.00.00.00.00.00.0
Trade payables1.73.52.14.65.25.04.83.6
Current liabilities11.19.813.517.923.554.430.939.5
Total liabilities13.611.814.919.325.256.132.852.8
Net debt(230.6)(188.4)(239.9)(166.2)(60.0)(257.5)(337.5)(346.8)
Debt / equity0.000.000.000.000.000.000.000.00
Current ratio22.6121.9818.9910.403.215.1117.699.70

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow(207.9)(29.6)(82.6)(80.3)(154.1)(103.4)(301.8)(221.8)
└ Capex(2.9)(0.4)(2.4)(0.1)(37.3)(2.1)(5.1)(45.9)
Free cash flow(210.8)(30.0)(85.0)(80.4)(191.4)(105.5)(306.9)(267.7)
Investing cash flow(155.7)11.761.673.3155.0(201.6)(462.1)145.1
Financing cash flow395.5(0.5)(1.1)(0.5)(0.8)299.5757.292.6
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash31.7(18.4)(22.1)(7.5)0.1(5.4)(6.7)15.8

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SUVEN at a glance

  • SUVEN closed at ₹269.4 on 20 Nov 2026, -2.71% on the day, +44.5% over one year, 33.2% below its 52-week high of ₹403.35.
  • Delivery was 48.1% of traded quantity on 20 Nov 2026, the 49th percentile of its own 3,629 sessions with a reading (20-session average 40.8%, 1-year average 42.9%).
  • Market capitalisation is ₹7,612 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-13.52).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹1 crore (+30.4% year on year), net profit ₹-107 crore; the price moved -4.1% on the first session after.
  • Promoters held 65.47% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 24 Jan 2027 and 3 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryHealthcare Research Analytics & Technology
ISININE495B01038
SeriesEQ
Listed23 Oct 2003
NSE market cap · 17 Nov 2026₹7,591 Cr
Free-float market cap (NSE)₹1,985 Cr
Shares outstanding (NSE)28.26Cr
History from24 Oct 2003
Sessions5,728
Turnover rank#985

Sector history

  1. to 5 Oct 2026Healthcare › Healthcare › Healthcare Services › Healthcare Research Analytics & Technology
  2. from 5 Oct 2026Index industry · Healthcare

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.